Selank
Heptapeptide research compound. Anxiolytic-pathway investigation.
RESTRICTED ACCESS
All products on this site are research chemicals sold strictly for laboratory and analytical purposes. Not for human or animal consumption. Confirm the following to enter.
I do not agree, exitCOGNITIVE & NOOTROPIC
Synthetic heptapeptide derived from ACTH (4-7). Neurotrophic and BDNF-pathway research.
ABOUT THIS COMPOUND
Semax is a synthetic heptapeptide developed from the N-terminus (residues 4-7) of adrenocorticotropic hormone (ACTH), extended with a Pro-Gly-Pro tail to resist enzymatic degradation. It is widely studied in neurotrophic-pathway, BDNF-pathway, and cognitive-pathway research.
Originally developed at the Russian Academy of Medical Sciences, Semax remains one of the most-investigated peptide nootropics in the literature. Solid-phase synthesized in our U.S. facility and HPLC-verified.
SPECIFICATIONS
RESEARCH APPLICATIONS
All applications are investigative. This compound is sold for research-use only and is not for human or animal consumption.
QUALITY ASSURANCE
A current-lot Certificate of Analysis is available for every compound. Email us with the product and lot number; we'll send the documentation. Read about our lab testing →
YOU MAY ALSO RESEARCH
QUESTIONS?
Lot questions, COA requests, institutional accounts, reach the team directly.
CONTACT US